| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | ABBOTT LABORATORIES CMN | Jun 30, 2026 | |
| Buy | ABBVIE INC. CMN | Jun 2, 2026 | |
| Sell | AbbVie Inc. Common Stock [Mo | May 5, 2026 | |
| Sell | ABBVIE INC.CMN JDS | Apr 24, 2026 | |
| Sell | ABBVIE INC.CMN JDS | Apr 23, 2026 | |
| Buy | ABBVIE INC CMN | Apr 15, 2026 | |
| Buy | ABBVIE INC CMN | Apr 15, 2026 | |
| Sell | ABBVIE INC.CMN JDS | Apr 11, 2026 | |
| Buy | ABBVIE INC CMN | Apr 10, 2026 | |
| Sell | ABBVIE ELECTRONIC INC | Apr 2, 2026 |
This page tracks congressional stock trading activity in AbbVie Inc. (ABBV) in the company_delisted sector. Disclosed Capitol has indexed 329 disclosed congressional trades involving ABBV. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 329 disclosed congressional trades in AbbVie Inc. (ABBV) — 133:90 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 30, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Jun 2, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 5, 2026 | Josh Gottheimer | D | Sell | $1,001 - $15,000 |
| Apr 24, 2026 | Michael McCaul | R | Sell | $50,001 - $100,000 |
| Apr 23, 2026 | Michael McCaul | R | Sell | $1,001 - $15,000 |
| Apr 15, 2026 | Diana Harshbarger | R | Buy | $15,001 - $50,000 |
| Apr 15, 2026 | Diana Harshbarger | R | Buy | $50,001 - $100,000 |
| Apr 11, 2026 | Michael McCaul | R | Sell | $50,001 - $100,000 |
| Apr 10, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 2, 2026 | Michael McCaul | R | Sell | $50,001 - $100,000 |
Across the 329 disclosed congressional trades in AbbVie Inc. (ABBV), members of Congress have reported 90 buys and 133 sells. The average 30-day alpha vs. the S&P 500 is -0.19%.
As of March 2026, AbbVie Inc. has 11 federal contract award records on file from USAspending.gov — most recently -$123K from the Department of Veterans Affairs on 2026-03-25.
| Award date | Agency | Amount |
|---|---|---|
| 2026-03-25 | Department of Veterans Affairs | -$123K |
| 2025-11-14 | Department of Health and Human Services · Indian Health Service | $52K |
| 2025-10-01 | Department of Veterans Affairs | $165K |
| 2025-10-01 | Department of Veterans Affairs | $113K |
| 2025-05-21 | Department of Veterans Affairs | $62K |
| 2025-04-16 | Department of Veterans Affairs | $62K |
| 2018-10-01 | Department of Veterans Affairs | $52K |
| 2017-10-12 | Department of Veterans Affairs | $54K |
| 2016-11-22 | Department of Veterans Affairs | $111K |
| 2016-10-17 | Department of Veterans Affairs | $64K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, AbbVie Inc. reported revenue of $61.16B and net income of $4.23B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $16.99B, net income $3.61B.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.